Forced swimming test in mice: A review of antidepressant activity

Psychopharmacology

Volumn 177, Issue 3, 2005, Pages 245-255

  Petit Demouliere, Benoit ^a   Chenu, Franck ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Antidepressants; Depression; Forced swimming test; Mouse; Screening; Strain

Indexed keywords

ANTIDEPRESSANT AGENT; WATER;

AGE DISTRIBUTION; ANIMAL HOUSING; AUTOMATION; CIRCADIAN RHYTHM; DEVICE; DIET RESTRICTION; DRUG ACTIVITY; DRUG EFFECT; ENVIRONMENTAL FACTOR; FOLLOW UP; FORCED SWIMMING TEST; GENDER; HUMAN; LABORATORY; MOUSE; MOUSE STRAIN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; SCORING SYSTEM; TANK; TIME; VALIDATION PROCESS; WATER TEMPERATURE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; HUMANS; MICE; PSYCHOPHARMACOLOGY; SWIMMING;

EID: 12344283814     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2048-7     Document Type: Review

References (103)

1. Alcaro A, Cabib S, Ventura R, Puglisi-Allegra S (2002) Genotype-and experience-dependent susceptibility to depressive-like responses in the forced-swimming test. Psychopharmacology 164:138-143
2. Aley KO, Kulkarni SK (1989) GABA-mediated modification of despair behavior in mice. Naunyn Schmiedebergs Arch Pharmacol 339:306-311
3. Alonso SJ, Castellano MA, Afonso D, Rodriguez M (1991) Sex differences in behavioral despair: relationships between behavioral despair and open field activity. Physiol Behav 49:69-72
4. Andreatini R, Bacellar LF (2000) Animal models: trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair. Prog Neuropsychopharmacol Biol Psychiatry 24:549-560
5. Anjaneyulu M, Chopra K, Kaur I (2003) Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 6:391-395
6. Arai I, Tsuyuki Y, Shiomoto H, Satoh M, Otomo S (2000) Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. Pharmacol Res 42:171-176
7. Baez M, Volosin M (1994) Corticosterone influences forced swim-induced immobility. Pharmacol Biochem Behav 49:729-736
8. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 70:187-192
9. Biziere K, Kan JP, Souilhac J, Muyard JP, Roncucci R (1982) Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. Arzneimittelforschung 32:824-831
10. Biziere K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R (1985) Minaprine, a new drug with antidepressant properties. Drugs Exp Clin Res 11:831-840
11. Bloch RG, Dooneief AS, Buchberg AS, Spellman S (1954) The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis. Ann Int Med 40:881-900
12. Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147-160
13. Bourin M (1990) Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? Fundam Clin Pharmacol 4:49-64
14. Bourin M, Colombel MC, Malinge M, Bradwejn J (1991) Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatry Neurosci 16:199-203
15. Bourin M, Redrobe JP, Hascoet M, Baker GB, Colombel MC (1996) A schematic representation of the psychopharmacological profile of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 20:1389-1402
16. Bourin M, Colombel MC, Redrobe JP, Nizard J, Hascoet M, Baker GB (1998) Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog Neuropsychopharmacol Biol Psychiatry 22:343-351
17. Bourin M, Fiocco AJ, Clenet F (2001) How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol 16:9-21
18. Browne RG (1979) Effects of antidepressants and anticholinergics in a mouse "behavioral despair" test. Eur J Pharmacol 58:331-334
19. Bunney WE, Jr, Davis JM (1965) Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry 13:483-494
20. Cabib S, Orsini C, Le Moal M, Piazza PV (2000) Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289:463-465
21. Cabib S, Puglisi-Allegra S, Ventura R (2002) The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 130:103-109
22. Clenet F, De Vos A, Bourin M (2001) Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice. Eur Neuropsychopharmacol 11:145-152
23. Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237-1264
24. Costa E, Garattini S, Valzelli L (1960) Interactions between reserpine, chlorpromazine, and imipramine. Experientia 16:461-463
25. Crabbe JC, Wahlsten D, Dudek BC (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670-1672
26. Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9:326-3577
27. Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucid I, Thomas SA (2001) Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298:651-657
28. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245
29. Dalvi A, Lucki I (1999) Murine models of depression. Psychopharmacology 147:14-16
30. Da-Rocha MA Jr, Puech AJ, Thiebot MH (1997) Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J Psychopharmacol 11:211-218
31. 1B receptors in old mice. Psychopharmacology 153:443-449
32. David DJ, Nic Dhonnchadha BA, Jolliet P, Hascoet M, Bourin M (2001) Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 119:203-211
33. David DJ, Renard CE, Jolliet P, Hascoet M, Bourin M (2003) Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology 166:373-382
34. De Graaf JS, Van Riezen H, Berendsen HHG, Van Delft AML (1985) A set of behavioural tests predicting antidepressant activity. Curr Trends Rev 5:291-301
35. Denenberg VH, Talgo NW, Waters NS, Kenner GH (1990) A computer-aided procedure for measuring swim rotation. Physiol Behav 47:1023-1025
36. Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43-46
37. Devoize JL, Rigal F, Eschalier A, Trolese JF (1982) Naloxone inhibits clomipramine in mouse forced swimming test. Eur J Pharmacol 78:229-231
38. Devoize JL, Rigal F, Eschalier A, Trolese JF, Renoux M (1984) Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacology 84:71-75
39. Dubocovich ML, Mogilnicka E, Areso PM (1990) Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol 182:313-325
40. Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321-1330
41. Easton A, Arbuzova J, Turek FW (2003) The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav 2:11-19
42. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54:994-1005
43. Eschalier A, Rigal F, Devoize JL, Trolese JF, Grillon C (1983) Morphine pretreatment reduces clomipramine effect in mouse forced-swimming test. Eur J Pharmacol 91:505-507
44. 1B de la serotonine et effets antidepresseurs des inhibiteurs de recapture selectif de la serotonine. CR Acad Sci Paris Life 324:433-441
45. Geyer MA, Markou A (2000) Animal models of psychiatric disorders. In: The American College of Neuropsychopharmacology (ed) The fourth generation of progress online. ACNP
46. Guo W, Todd K, Bourin M, Hascoet M, Kouadio F (1996) Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol Biochem Behav 54:725-7300
47. Harkin AJ, Bruce KH, Craft B, Paul IA (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372:207-213
48. Heninger GR, Delgado PL, Charney DS (1996) The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29:2-11
49. Hilakivi LA, Ota M, Lister RG (1989) Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral 'despair'. Pharmacol Biochem Behav 33:371-374
50. Hirani K, Khisti RT, Chopde CT (2002) Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20- one. Neuropharmacology 43:1339-1350
51. Hohnes A (2003a) Mouse behavioral models of anxiety and depression. In: Crawley JN (ed) Mouse behavioral phenotyping. Society for Neuroscience, Washington D.C., pp 43-47
52. Hohnes PV (2003b) Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 15:143-174
53. Holmes A, Yang RJ, Murphy DL, Crawley JN (2002) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27:914-9233
54. Hyman SE, Nestler EJ (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 153:151-162
55. Karolewicz B, Paul IA (2001) Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol 415:197-201
56. Kato M, Katayama T, Iwata H, Yamamura M, Matsuoka Y, Narita H (1998) In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin. J Pharmacol Exp Ther 284:983-990
57. Khisti RT, Chopde CT, Jain SP (2000) Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67:137-143
58. Klerman GL, Cole JO (1965) Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17:101-141
59. Krahe TE, Filgueiras CC, Schmidt SL (2002) Effects of rotational side preferences on immobile behavior of normal mice in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 26:169-176
60. Kuhn R (1957) Treatment of depressive states with an iminodibenzyl derivative (G 22355). Schweiz Med Wochenschr 87:1135-1140
61. Loomer HP, Saunders JC, Kline NS (1957) A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc 135:129-141
62. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532
63. Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155:315-322
64. Luttinger D, Freedman M, Hamel L, Ward SJ, Perrone M (1985) The effects of serotonin antagonists in a behavioral despair procedure in mice. Eur J Pharmacol 107:53-58
65. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT, Fahnestock M (2001) Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115:1145-11533
66. Malinge M, Bourin M, Colombel MC, Larousse C (1988) Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test. Psychopharmacology 96:104-109
67. Miura H, Naoi M, Nakahara D, Ohta T, Nagatsu T (1996) Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice. Pharmacol Biochem Behav 53:469-475
68. Mogilnicka E, Czyrak A, Maj J (1987) Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol 138:413-416
69. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ (2004) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 101:10827-10832
70. Nestler EJ (1998) Antidepressant treatments in the 21st century. Biol Psychiatry 44:526-533
71. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, Hen R, Koester S, Lederhendler I, Meaney M, Robbins T, Winsky L, Zalcman S (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52:503-528
72. Nomura S, Shimizu J, Kinjo M, Kametani H, Nakazawa T (1982) A new behavioral test for antidepressant drugs. Eur J Pharmacol 83:171-175
73. O'Neil MF, Moore NA (2003) Animal models of depression: are there any? Hum Psychopharmacol 18:239-254
74. Porsolt RD (2000) Animal models of depression: utility for transgenic research. Rev Neurosci 11:53-58
75. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336
76. Porsolt RD, Bertin A, Jalfre M (1978) "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291-294
77. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201-210
78. Raghavendra V, Kaur G, Kulkarni SK (2000) Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol 10:473-481
79. Redrobe JP, Pinot P, Bourin M (1996) The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam Clin Pharmacol 10:524-5288
80. Redrobe JP, Bourin M, Colombel MC, Baker GB (1998) Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 138:1-8
81. Rogoz Z, Skuza G, Maj J (1999) Pharmacological profile of milnacipran, a new antidepressant, given acutely. Pol J Pharmacol 51:317-322
82. Schechter MD, Chance WT (1979) Non-specificity of "behavioral despair" as an animal model of depression. Eur J Pharmacol 60:139-142
83. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522
84. Schramm NL, McDonald MP, Limbird LE (2001) The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21:4875-4882
85. Scotto di Tella AM, Mercier J (1981) Influence of the procedure of administration in the activity of some antidepressant or disinhibiting drugs upon behavioural despair (author's transl). J Pharmacol 12:179-188
86. Selikoff IJ, Robitzek EH (1952) Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest 21:385-438
87. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137
88. Slattery DA, Hudson AL, Nutt DJ (2004) Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 18:1-21
89. Stenger A, Couzinier JP, Briley M (1987) Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-amino-methylcyclopropane hydrochloride (F 2207), a new potential antidepressant. Psychopharmacology 91:147-153
90. Sunal R, Gumusel B, Kayaalp SO (1994) Effect of changes in swimming area on results of "behavioral despair test". Pharmacol Biochem Behav 49:891-896
91. Szymczyk G, Zebrowska-Lupina I (2000) Influence of antiepileptics on efficacy of antidepressant drugs in forced swimming test. Pol J Pharmacol 52:337-344
92. Taltavull JF, Chefer VI, Shippenberg TS, Kiyatkin EA (2003) Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim. Brain Res 975:244-247
93. Thierry B, Stem L, Simon P, Porsolt RD (1986) The tail suspension test: ethical considerations. Psychopharmacology 90:284-285
94. Voikar V, Koks S, Vasar E, Rauvala H (2001) Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 72:271-281
95. Wahlsten D, Metten P, Phillips TJ, Boehm SL II, Burkhart-Kasch S, Dorow J, Doerksen S, Downing C, Fogarty J, Rodd-Henricks K, Hen R, McKinnon CS, Merrill CM, Nolte C, Schalomon M, Schlumbohm JP, Sibert JR, Wenger CD, Dudek BC, Crabbe JC (2003) Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 54:283-311
96. West AP (1990) Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 14:863-877
97. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1-16
98. Willner P, Mitchell PJ (2002) The validity of animal models of predisposition to depression. Behav Pharmacol 13:169-1888
99. Wong ML, Licinio J (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3:136-151
100. Yates G, Panksepp J, Ikemoto S, Nelson E, Conner R (1991) Social isolation effects on the "behavioral despair" forced swimming test: effect of age and duration of testing. Physiol Behav 49:347-353
101. Yoshikawa T, Watanabe A, Ishitsuka Y, Nakaya A, Nakatani N (2002) Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. Genome Res 12:357-366
102. Zeller EA, Barsky J (1952) In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med 81:459-461
103. Zocchi A, Varnier G, Arban R, Griffante C, Zanetti L, Bettelini L, Marchi M, Gerrard PA, Corsi M (2003) Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci Lett 345:73-76